These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 10213269

  • 1. Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis.
    Mlambo NC, Hylander B, Brauner A.
    Inflammation; 1999 Apr; 23(2):131-9. PubMed ID: 10213269
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY, Chen WP, Fu LW, Yang LY, Huang TP.
    Adv Perit Dial; 1997 Apr; 13():64-71. PubMed ID: 9360653
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A, Hylander B, Wretlind B.
    Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Growth factors in continuous ambulatory peritoneal dialysis effluent. Their relation with peritoneal transport of small solutes.
    Lai KN, Lai KB, Szeto CC, Lam CW, Leung JC.
    Am J Nephrol; 1999 Mar; 19(3):416-22. PubMed ID: 10393381
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1.
    Brauner A, Hertting O, Alkstrand E, Sandberg E, Chromek M, Chen ZW, Ostenson CG.
    Perit Dial Int; 2003 Mar; 23(1):5-13. PubMed ID: 12691501
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S, Nasini MG, Ravera M, Sanna A, Tirotta A, Lamperi S.
    Adv Perit Dial; 1997 Mar; 13():7-12. PubMed ID: 9360642
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD.
    Zemel D, Betjes MG, Dinkla C, Struijk DG, Krediet RT.
    Perit Dial Int; 1995 Mar; 15(2):134-41. PubMed ID: 7612733
    [Abstract] [Full Text] [Related]

  • 19. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.
    Pannekeet MM, Zemel D, Koomen GC, Struijk DG, Krediet RT.
    Perit Dial Int; 1995 Mar; 15(6):217-25. PubMed ID: 7578497
    [Abstract] [Full Text] [Related]

  • 20. Development of an in-vitro model to study the growth characteristics of Staphylococcus epidermidis in continuous ambulatory peritoneal dialysis.
    Brant JA, Hanlon GW, Denyer SP.
    J Pharm Pharmacol; 1998 Oct; 50(10):1195-203. PubMed ID: 9821670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.